Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bryan Oronsky

Showing results (61-70 of 115) with videos related to

Pageof 12
Sort By:
Journal of Cancer|August 1, 2022
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)Bryan Oronsky, Nacer Abrouk, Scott Caroen, et al.
Cancer Metastasis Reviews|August 23, 2024
Lost at SCLC: a review of potential platinum sensitizersBryan Oronsky, Nacer Abrouk, Li Mao, et al.
Investigational New Drugs|February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizerBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Plos One|July 10, 2014
The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditionsMarcel H Fens, Sandra K Larkin, Bryan Oronsky, et al.
Case Reports in Oncology|April 3, 2023
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma PatientSantosh Kesari, Jeannie Williams, Erica Burbano, et al.
Expert Opinion on Therapeutic Targets|April 2, 2020
TGF-beta: a master immune regulatorChristopher Larson, Bryan Oronsky, Corey A Carter, et al.
Medical Oncology (Northwood, London, England)|April 27, 2017
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancerBryan Oronsky, Carolyn M Ray, Alexander I Spira, et al.
Redox Biology|July 13, 2015
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001Jan Scicinski, Bryan Oronsky, Shoucheng Ning, et al.
Oncotarget|August 18, 2015
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001Shoucheng Ning, Thillai Veerapazham Sekar, Jan Scicinski, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2017
RRx-001 protects against cisplatin-induced toxicitiesBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Pageof 12

Showing results (61-70 of 115) with videos related to

Sort By:
Pageof 12
Journal of Cancer|August 1, 2022
A 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC)Bryan Oronsky, Nacer Abrouk, Scott Caroen, et al.
Cancer Metastasis Reviews|August 23, 2024
Lost at SCLC: a review of potential platinum sensitizersBryan Oronsky, Nacer Abrouk, Li Mao, et al.
Investigational New Drugs|February 5, 2016
RRx-001, A novel dinitroazetidine radiosensitizerBryan Oronsky, Jan Scicinski, Shoucheng Ning, et al.
Plos One|July 10, 2014
The capacity of red blood cells to reduce nitrite determines nitric oxide generation under hypoxic conditionsMarcel H Fens, Sandra K Larkin, Bryan Oronsky, et al.
Case Reports in Oncology|April 3, 2023
Case Report of AdAPT-001-Mediated Sensitization to a Previously Failed Checkpoint Inhibitor in a Metastatic Chordoma PatientSantosh Kesari, Jeannie Williams, Erica Burbano, et al.
Expert Opinion on Therapeutic Targets|April 2, 2020
TGF-beta: a master immune regulatorChristopher Larson, Bryan Oronsky, Corey A Carter, et al.
Medical Oncology (Northwood, London, England)|April 27, 2017
A brief review of the management of platinum-resistant-platinum-refractory ovarian cancerBryan Oronsky, Carolyn M Ray, Alexander I Spira, et al.
Redox Biology|July 13, 2015
NO to cancer: The complex and multifaceted role of nitric oxide and the epigenetic nitric oxide donor, RRx-001Jan Scicinski, Bryan Oronsky, Shoucheng Ning, et al.
Oncotarget|August 18, 2015
Nrf2 activity as a potential biomarker for the pan-epigenetic anticancer agent, RRx-001Shoucheng Ning, Thillai Veerapazham Sekar, Jan Scicinski, et al.
Journal of Cancer Research and Clinical Oncology|April 19, 2017
RRx-001 protects against cisplatin-induced toxicitiesBryan Oronsky, Tony R Reid, Christopher Larson, et al.
Pageof 12